Evaluation of Safety and Efficacy of Supportan® Drink
- Cancer
- Malnutrition (Calorie)
At a glance
- Phase
- Phase not stated
- Study type
- Interventional
- Sponsor
- Fresenius Kabi Taiwan Ltd.
- Enrolment target
- 135
- Started
- 8 April 2025
- Main results due
- 31 December 2027
- Study sites
- 1
- Registry updated
- 28 September 2026
Can you take part?
- Aged 18 years and over.
- Open to any sex.
- You need the condition being studied — healthy volunteers are not accepted.
These are the headline rules only. Every study has a longer list, and whether you are eligible is decided by the research team at the site — never by this page.
Read the full eligibility criteria
Inclusion Criteria: 1\. Patients receiving chemotherapy and/or radiotherapy, or immunotherapy, or targeted therapy; Exclusion Criteria: 1\. Patient with documented diagnosis of liver, kidney or heart disease in the hospital's electronic medical record (EMR); severity of disease evaluated by Investigator as not being suitable to participate in this study;
What this study is about
In the sponsor’s own words, from the registry.
The goal of this clinical trial is to demonstrate safety and efficacy of Supportan® Drink
Study sites(1)
Keelung Chang Gung Memorial Hospital-Lover's lake branch
Keelung, Taiwan, Taiwan
Recruiting
Showing 1 of 1 sites. 1 of the 1 site on this study is recruiting right now — a site can stop enrolling while the study as a whole is still open.
Source: ClinicalTrials.gov record NCT06902402. Trialion does not run this study, is not paid to refer anyone to it, and cannot enrol you. Eligibility is always decided by the research team at the site.
Not the right study?
Answer three questions and see the studies recruiting near you, in plain language.
Find a study for me